Community protocol

Body Recomposition Phase 3

The main weight loss goal has been met. ~195 lb and <15% body fat. Now it's time to lean down from 15% body fat to sub 12%. While nursing a shoulder and opposite elbow injury.

198 lbs

70 in

male

By

Weight

GLP-2

Metabolic

Growth

tes

Metabolic

Healing

ghk

Longevity

Healing

wol

Longevity

For research purposes only.

Peptide Mind does not endorse this protocol. This is a user-generated research reference — not for human consumption or therapeutic use.

Log your research schedule

Add this research protocol to your calendar or print a reference copy for your lab records. For research purposes only.

Peptide Protocol Schedule

A day-by-day view of this protocol. Tap any day to see which peptides are active. Circle size reflects how many peptides are scheduled; colored dots below represent individual peptides.

July 2026
Sun
Mon
Tue
Wed
Thu
Fri
Sat
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1

tes

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)

evening

subcutaneous

600 mcg

ghk

GHK-Cu

evening

subcutaneous

2 mg

wol

Wolverine Blend (BPC-157, TB-500)

evening

subcutaneous

400 mcg

Daily Dosing Breakdown

A grouped breakdown of which peptides to take throughout this protocol. Consecutive days with the same schedule are combined. Days with no doses are omitted.

Jul 22–24, 2026

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Jul 25–26, 2026

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Jul 27, 2026

GLP-2 (Tirzepatide)5 mg · Morning

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Jul 28–31, 2026

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Aug 1–2, 2026

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Aug 3, 2026

GLP-2 (Tirzepatide)5 mg · Morning

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Aug 4–7, 2026

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Aug 8–9, 2026

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Aug 10, 2026

GLP-2 (Tirzepatide)5 mg · Morning

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Aug 11–14, 2026

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Aug 15–16, 2026

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Aug 17, 2026

GLP-2 (Tirzepatide)5 mg · Morning

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Aug 18–21, 2026

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Aug 22–23, 2026

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Aug 24, 2026

GLP-2 (Tirzepatide)5 mg · Morning

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Aug 25–28, 2026

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Aug 29–30, 2026

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Aug 31, 2026

GLP-2 (Tirzepatide)5 mg · Morning

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Sep 1–4, 2026

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Sep 5–6, 2026

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Sep 7, 2026

GLP-2 (Tirzepatide)5 mg · Morning

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Sep 8–11, 2026

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Sep 12–13, 2026

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Sep 14, 2026

GLP-2 (Tirzepatide)5 mg · Morning

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

GHK-Cu2 mg · Evening

Wolverine Blend (BPC-157, TB-500)400 mcg · Evening

Sep 15–18, 2026

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

Sep 21–25, 2026

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

Sep 28 – Oct 2, 2026

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

Oct 5–9, 2026

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

Oct 12, 2026

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)600 mcg · Evening

Weekly Schedule

Day-of-week breakdown for each peptide in this protocol.

Mon
Tue
Wed
Thu
Fri
Sat
Sun

GLP-2

GLP-2 (Tirzepatide)

morning

subcutaneous

5 mg

Cycle Duration
7 weeks 6 days

Total Peptide Requirements

The total quantity of each peptide needed to complete this protocol, calculated from dosage and duration.

Weight

GLP-2

Metabolic

GLP-2 (Tirzepatide)

5 mg · weekly · Morning

39.3

Growth

tes

Metabolic

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)

0.6 mg · 5× weekly · Evening

35.6

Skin

ghk

Longevity

GHK-Cu

2 mg · 5× weekly · Evening

78.6

Healing

wol

Longevity

Wolverine Blend (BPC-157, TB-500)

0.4 mg · 7× weekly · Evening

22

Know exactly what to draw

Enter your vial concentration and we'll calculate the precise injection volume for every peptide in this protocol.

Protocol Body Targets

The biological systems and tissue targets addressed by the 4 peptides in this protocol.

6

Body Targets

4 peptides

Metabolic

Regulates fat metabolism, insulin sensitivity, and energy use.

GLP-2 (Tirzepatide), Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)

Gut

Supports gut lining integrity, digestion, and the gut-brain axis.

GLP-2 (Tirzepatide), Wolverine Blend (BPC-157, TB-500)

Hormones

Influences hormone signaling pathways and endocrine balance.

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)

Skin

Promotes collagen synthesis, wound healing, and skin elasticity.

GHK-Cu

Muscle

Enhances muscle growth, repair, and recovery after exercise.

Wolverine Blend (BPC-157, TB-500)

Joints & Bone

Supports cartilage integrity, bone density, and joint mobility.

Wolverine Blend (BPC-157, TB-500)

Protocol targeted areas

Build your own protocol

Create a custom peptide stack tailored to your goals. Add peptides, set dosages, and share it with the community.

Protocol Duration & Timeline

A visual breakdown of each peptide's active window within this protocol. Use this to understand the total cycle length and how each compound's duration compares to the full protocol.

GLP-2 (Tirzepatide)

5 mg once per week

55 days

Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin)

600 mcg 5x per week

83 days

GHK-Cu

2 mg 5x per week

55 days

Wolverine Blend (BPC-157, TB-500)

400 mcg 7x per week

55 days

Protocol Peptides

Each peptide included in this protocol with its dosing amount, frequency, and administration details.

Browse other protocols

View all
Immunity111 days

MOTS-C

Longevity

mot

Longevity111 days

Retatrutide

Weight

GLP-3

Healing111 days

Tesamorelin

Weight

tesa

Healing

ghk

Healing

bpc

Weight

cjc

Frequently asked questions

What is a peptide dosage calculator?

A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringe units to draw. This calculator works for single peptide compounds and multi-peptide blends.

How do I calculate peptide dosage from a vial?

To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.

How much Bacteriostatic water should I add to a peptide vial?

Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.

How are peptides different from proteins?

Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.​